Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: A retrospective analysis

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 381-386

  Cox, S K ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANOFLOXACIN; DIFLOXACIN; MARBOFLOXACIN; MOXIFLOXACIN;

ALLOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG ELIMINATION; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; AZA COMPOUNDS; CIPROFLOXACIN; FLUOROQUINOLONES; HUMANS; QUINOLINES; QUINOLONES; RETROSPECTIVE STUDIES; SPECIES SPECIFICITY;

EID: 34548445015     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00886.x     Document Type: Article

References (48)

1. Aliabadi, F.S. Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62, 1979 1989.
2. Aliabadi, F.S. Lees, P. (2002) Pharmacokinetics and pharmacokinetic/ pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25, 161 174.
3. Aliabadi, F.S., Ali, B.H., Landoni, M.F. Lees, P. (2003a) Pharmacokinetics and PK-PD modeling of danofloxacin in camel serum and tissue cage fluids. The Veterinary Journal, 165, 104 118.
4. Aliabadi, F.S., Landoni, M.F. Lees, P. (2003b) Pharmacokinetics (PK), Pharmacodynamics (PD) and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47, 626 635.
5. Atef, M., El-Gendi, A.Y., Aziza Amer, M.M. Abd El-Aty, A.M. (2001) Some pharmacokinetic data for danofloxacin in healthy goats. Veterinary Research Communications, 25, 367 377.
6. Atef, M., El-Banna, H.A., Abd El-Aty, A.M. Goudah, A. (2002) Pharmacokinetics of difloxacin in goats. Dtsch tierarztl Wschr, 109, 320 323.
7. Bergogne-Berezin, E. (2002) Clinical role of protein binding of quinolones. Clinical Pharmacokinetics, 41, 741 750.
8. Bousquet-Melou, A., Bernard, S., Schneider, M. Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal, 34, 366 372.
9. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep and cows. American Journal of Veterinary Research, 60, 1111 1116.
10. Carretero, M., Rodriguez, M.I., SanAndres, M.I., Fores, P., DeLucas, J.J., Nieto, J., Waxman, S., SanAndres, M.D. Gonzalez, F. (2002) Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 34, 360 365.
11. Cox, S.K., Cottrell, M.B., Smith, L., Papich, M.G., Frazier, D.L. Bartges, J. (2004) Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species. Journal of Veterinary Pharmacology and Therapeutics, 27, 139 146.
12. EMEA (1996). European Agency for the Evaluation of Medicinal Products, Veterinary Medicines and Information Technology Unit. Marbofloxacin Summary Report. Available from: http://www.emea.europe.eu/pdfs/vet/mrls/007996en.pdf (accessed 19 March 2007).
13. Fernandez-Varon, E., Villamayor, L., Escudero, E., Espuny, A. Carceles, C.M. (2005a) Pharmacokinetics and mile penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. The Veterinary Journal, 172, 302 307.
14. Fernandez-Varon, E., Bovaira, M.J., Espuny, A., Escudero, E., Vancraeynest, D. Carceles, C.M. (2005b) Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 343 348.
15. Fernandez-Varon, E., Carceles, C.M., Marin, P., Martos, N., Escudero, E. Ayala, I. (2006) Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses. American Journal of Veterinary Research, 67, 1076 1081.
16. Fernandez-Varon, E., Carceles, C.M., Marin, P., Vancraeynest, D., Montes, A., Sotillo, J. Garcia, J.D. (2007) Disposition kinetics and pharmacokinetics-pharmacodynamic integration of difloxacin against Staphylococcus aureus isolates from rabbits. Research in Veterinary Science, in press, doi: 10.1016/j.rvsc.2007.04.002.
17. Inui, T., Taira, T., Matsushita, T. Endo, T. (1998) Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken. Xenobiotica, 28, 887 893.
18. Ismail, M. El-Kattan, Y.A. (2007) Comparative pharmacokinetics of marbofloxacin in healthy and mannheimia haemolytica infected calves. Research in Veterinary Science, 82, 398 404.
19. Kietzmann, M. (1999) Overview of the pharmacokinetic properties of fluoroquinolones in companion animals. Compendium on Continuing Education for the Practicing Veterinarian, 21, 7 11.
20. Knoll, U., Glünder, G. Kietzmann, M. (1999) Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens. Journal of Pharmacology Therapeutics, 22, 239 246.
21. Lefebvre, H.P., Schneider, M., Dupouy, V., Laroute, V., Costes, G., Delesalle, L. Toutain, P.L. (1998) Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog. Journal of Veterinary Pharmacology and Therapeutics, 21, 453 461.
22. Lindercrona, R.H., Friis, C. Nielsen, J.P. (2000) Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs. Research in Veterinary Science, 68, 211 216.
23. Lode, H., Hoffken, G., Borner, K. Koeppe, P. (1989) Unique aspects of quinolone pharmacokinetics. Clinical Pharmacokinetics, 16 (Suppl. 1 1 4.
24. Mahmood, I. (1999) Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. Journal of Pharmacy and Pharmacology, 51, 905 910.
25. Marbocyl (2005). Marbocyl pharmacokinetics. Available from: http://www.marbocyl.com/cgilocal/livre_html.pl?famille=122&langue=5 (accessed 28 October 2004).
26. Marin, P., Escudero, E., Fernandez-Varon, E. Carceles, C.M. (2007a) Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Journal of Veterinary Pharmacology and Therapeutics, 30, 74 79.
27. Marin, P., Fernandez-Varon, E., Escudero, E. Carceles, C.M. (2007b) Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep. Research in Veterinary Science, 83, 234 238.
28. Martinez, M., McDermott, P. Walker, R. (2006) Pharmacology of fluoroquinolones: perspective for the use in domestic animals. The Veterinary Journal, 172, 10 28.
29. McKellar, Q.A., Gibson, I.F. Mc Cormack, R.Z. (1998) Pharmacokinetics and tissue disposition of danofloxacin in sheep. Biopharmaceutics & Drug Disposition, 19, 123 129.
30. Moise, P.A., Birmingham, M.C. Schentag, J.J. (2000) Pharmacokinetics and metabolism of moxifloxacin. Drugs of Today, 36, 229 244.
31. Nouws, J.F.M., Mevius, D.J., Vree, T.B., Baars, A.M. Laurensen, J. (1988) Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. The Veterinary Quarterly, 10, 156 163.
32. Papich, M.G. Riviere, J.E. (2001) Fluoroquinolone antimicrobial drugs. In Veterinary Pharmacology and Therapeutics, pp. 898 918. Blackwell Publishing, Ames, IA.
33. Pashov, D.A., Lashev, L.D., Matev, I.B. Kanelov, I.N. (1997) Interspecies comparisons of plasma half-live of trimethoprim in relation to body mass. Journal of Veterinary Pharmacology and Therapeutics, 20, 48 53.
34. Peyrou, M., Doucet, M.Y., Vrins, A., Laroute, V. Bousquet-Melou, A. (2005) Marbofloxacin and enrofloxacin in horses: comparison of pharmacokinetic parameters and use of urinary data to estimate first-pass effect and absorbed fraction. Journal of Veterinary Pharmacology and Therapeutics, 28, 283 288.
35. Riviere, J.E. (1999) Interspecies extrapolations. In Comparative Pharmacokinetics. Principles, Techniques and Applications, pp. 296 307. Iowa State University Press, Ames, IA.
36. Riviere, J.E., Martin-Jimenez, T., Sundlof, S.F. Craigmill, A.L. (1997) Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. Journal of Veterinary Pharmacology and Therapeutics, 20, 453 463.
37. Sarasola, P., Lees, P., AliAbadi, F.S., McKellar, Q.A., Donachie, W., Marr, K.A., Sunderland, S.J. Rowan, T.G. (2002) Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with mannheimia (pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy, 46, 3013 3019.
38. Shem-Tov, M., Ziv, G., Glickman, A. Saran, A. (1997) Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Journal of Veterinary Medicine A, 44, 511 519.
39. Shem-Tov, M., Ziv, G., Glickman, A. Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of ewes. Journal of Veterinary Medicine, 28, 571 579.
40. Siefert, H.M., Maruhn, D., Maul, W., Forster, D. Ritter, W. (1986) Pharmacokinetics of ciprofloxacin. Arzneimittel Forschung, 36, 1496 1502.
41. Siefert, H.M., Domdey-Bette, A., Henninger, K., Hucke, F., Kohlsdorfer, C. Stass, H.H. (1999a) Pharmacokinetics of the 8-methoxyquinolone, moxifloxin: a comparison in humans and other mammalian species. Journal of Antimicrobial Chemotherapy, 43, 69 76.
42. Siefert, H.M., Kohlsdorfer, C., Steinke, W. Witt, A. (1999b) Pharmacokinetics of 8 methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy, 43, 61 67.
43. Sorgel, F. (1989) Metabolism of gyrase inhibitors. Reviews of Infectious Diseases, 11, S1119 S1129.
44. Stass, H. Kubitza, D. (1999) Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. Journal of Antimicrobial Chemotherapy, 43, 83 90.
45. Waxman, S., Rodriguez, C., Gonzalez, F., De Vicente, M.L., San Andres, M.I. San Andres, M.D. (2001) Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats. Journal of Veterinary Pharmacology and Therapeutics, 24, 375 378.
46. Waxman, S., San Andres, M.D., Gonzalez, F., San Andres, M.I., De Lucas, J.J. Rodriguez, C. (2004) Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics, 27, 31 35.
47. WHO (1997). World Health Organization, International Programme on Chemical Safety, Toxicological Evaluation of Certain Veterinary Drug Residues in Food, Danofloxacin (WHO Food Additives Series 39). Available from: http://www.inchem.org/documents/jecfa/jecmono/v39je04.htm (accessed 28 October 2004).
48. Wise, R., Andrews, J.M., Marshall, G. Hartman, G. (1999) Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration. Antimicrobial Agents and Chemotherapy, 43, 1508 1510.